Pharmacokinetics of cyclosporine A in patients with nephrotic syndrome.
Vernillet
L
L
Sandoz Laboratories, Rueil-Malmaison, France.
Moulin
B
B
Dadoun
C
C
Le Bigot
J F
JF
Fillastre
J P
JP
D000284:Administration, Oral; D000328:Adult; D001055:Apolipoproteins B / Q000097:blood; D001682:Biological Availability; D002784:Cholesterol / Q000097:blood; D002851:Chromatography, High Pressure Liquid; D003524:Cyclosporins / Q000097:blood / Q000493:pharmacokinetics*; D006801:Humans; D007275:Injections, Intravenous; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000378:metabolism*; D012709:Serum Albumin / Q000378:metabolism
D001055:Apolipoproteins B; D003524:Cyclosporins; D012709:Serum Albumin; D002784:Cholesterol